Showing 1 - 10 results of 10 for search 'Susan van den Hof', query time: 0.03s
Refine Results
-
1
The Effects of Psycho-Emotional and Socio-Economic Support for Tuberculosis Patients on Treatment Adherence and Treatment Outcomes - A Systematic Review and Meta-Analysis. by Rosa van Hoorn, Ernesto Jaramillo, David Collins, Agnes Gebhard, Susan van den Hof
Published 2016-01-01Get full text
Article -
2
Correction: Impact on Patients' Treatment Outcomes of XpertMTB/RIF Implementation for the Diagnosis of Tuberculosis: Follow-Up of a Stepped-Wedge Randomized Clinical Trial. by Anete Trajman, Betina Durovni, Valeria Saraceni, Alexandre Menezes, Marcelo Cordeiro-Santos, Frank Cobelens, Susan Van den Hof
Published 2016-01-01Get full text
Article -
3
Cost-effectiveness of tuberculosis infection screening and treatment among high-tuberculosis risk immigrants and asylum seekers in The Netherlands: A cohort modelling study by Jan A.C. Hontelez, Ineke T. Spruijt, Roel Bakker, Frank Cobelens, Connie Erkens, Susan van den Hof, Sake J. de Vlas
Published 2025-10-01Get full text
Article -
4
Testing behaviour and positivity for SARS-CoV-2 infection: insights from web-based participatory surveillance in the Netherlands by Jacco Wallinga, Scott A McDonald, Albert Jan Van Hoek, C Maarten A Schipper, Susan van den Hof, Lucia C Soetens, Ingrid Friesema, Cees C van den Wijngaard, Anne Teirlinck, Nienke Neppelenbroek
Published 2021-12-01Get full text
Article -
5
Prospective cohort study of fatigue before and after SARS-CoV-2 infection in the Netherlands by Anne J. Huiberts, Siméon de Bruijn, Stijn P. Andeweg, Christina E. Hoeve, Maarten Schipper, Hester E. de Melker, Janneke HHM van de Wijgert, Susan van den Hof, Cees C. van den Wijngaard, Mirjam J. Knol
Published 2025-03-01Get full text
Article -
6
Post-acute sequelae of COVID-19 3 to 12 months after infection: Delta vs Omicron by Siméon de Bruijn, Anna D. Tulen, Jeroen Rodenburg, Hendriek Boshuizen, Maarten Schipper, Elizabeth N. Mutubuki, Hans Knoop, Eelco Franz, Tessa van der Maaden, Susan van den Hof, Albert Jan van Hoek, Cees C. van den Wijngaard
Published 2025-01-01Get full text
Article -
7
Cohort profile: an observational population-based cohort study on COVID-19 vaccine effectiveness in the Netherlands – the VAccine Study COVID-19 (VASCO) by Diederick E Grobbee, Gerco den Hartog, Hester E de Melker, Susan van den Hof, Marjolein N Kooijman, Anne J Huiberts, Christina E Hoeve, Susan JM Hahné, Rob van Binnendijk, Janneke HHM van de Wijgert, Mirjam J Knol
Published 2024-10-01Get full text
Article -
8
Use of Xpert MTB/RIF in Decentralized Public Health Settings and Its Effect on Pulmonary TB and DR-TB Case Finding in India. by Kuldeep Singh Sachdeva, Neeraj Raizada, Achuthan Sreenivas, Anna H Van't Hoog, Susan van den Hof, Puneet K Dewan, Rahul Thakur, R S Gupta, Shubhangi Kulsange, Bhavin Vadera, Ameet Babre, Christen Gray, Malik Parmar, Mayank Ghedia, Ranjani Ramachandran, Umesh Alavadi, Nimalan Arinaminpathy, Claudia Denkinger, Catharina Boehme, C N Paramasivan
Published 2015-01-01Get full text
Article -
9
Programmatic Management of Drug-Resistant Tuberculosis: An Updated Research Agenda. by Carole D Mitnick, Carly A Rodriguez, Marita L Hatton, Grania Brigden, Frank Cobelens, Martin P Grobusch, Robert Horsburgh, Christoph Lange, Christian Lienhardt, Eyal Oren, Laura J Podewils, Barbara Seaworth, Susan van den Hof, Charles L Daley, Agnes C Gebhard, Fraser Wares, RESIST-TB (Research Excellence to Stop TB Resistance) and GDI (Global Drug Resistant TB Initiative)
Published 2016-01-01Get full text
Article -
10
Spatio-temporal forecasting of COVID-19 cases in the Netherlands for source and contact tracing by Max Keuken, Jizzo R. Bosdriesz, Anders Boyd, Elisabeth M. den Boogert, Ivo K. Joore, Nicole H.T.M. Dukers – Muijrers, Gini van Rijckevorsel, Hannelore M. Götz, Irene E. Goverse, Mariska W.F. Petrignani, Stijn F.H. Raven, Susan van den Hof, Kirsten V.C. Wevers-de Boer, Maarten F. Schim van der Loeff, Amy Matser
Published 2025-05-01Get full text
Article